BioNTech SE American Depositary Share Earnings Dividend

BioNTech SE American Depositary Share’s revenue fell -59.51% since last year same period to $105.6Mn in the Q2 2026. On a quarterly growth basis, BioNTech SE American Depositary Share has generated -12.03% fall in its revenue since last 3-months.

BioNTech SE American Depositary Share’s net profit fell -112.31% since last year same period to $-820.8Mn in the Q2 2026. On a quarterly growth basis, BioNTech SE American Depositary Share has generated -51.82% fall in its net profits since last 3-months.

BioNTech SE American Depositary Share’s net profit margin fell -424.35% since last year same period to -777.27% in the Q2 2026. On a quarterly growth basis, BioNTech SE American Depositary Share has generated -72.58% fall in its net profit margins since last 3-months.

BioNTech SE American Depositary Share’s earning per share (EPS) estimates for the current quarter stand at 0.82 - a 131.78% jump from last quarter’s estimates.

BioNTech SE American Depositary Share’s earning per share (EPS) estimates for the current year stand at 0.82.

BioNTech SE American Depositary Share’s earning per share (EPS) fell -89.37% since last year same period to -3.03 in the Q2 2026. This indicates that the BioNTech SE American Depositary Share has generated -89.37% annual rate of fall in its earning per share (EPS) in the last 4 quarters.